Novavax (NVAX) Cash from Operations (2010 - 2026)

Novavax's Cash from Operations history runs 17 years deep, the most recent figure standing at 32400000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 82.53% year-over-year to 32400000.0; the TTM figure through Mar 2026 stood at 91533000.0 (up 51.62% YoY), while the FY2025 annual figure was 244635000.0, down 180.34% from the prior year.
• Cash from Operations was 32400000.0 for Q1 2026 at Novavax, up from 39475000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 314269000.0 in Q2 2024 to a low of 325593000.0 in Q1 2023.
• Historically, Cash from Operations has averaged 87894235.29 across 5 years, with a median of 117816000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Cash from Operations sank 267.86% in 2023, then soared 282.78% in 2024.
• A 5-year view of Cash from Operations shows it stood at 117816000.0 in 2022, then plunged by 50.05% to 176781000.0 in 2023, then grew by 2.05% to 173163000.0 in 2024, then soared by 77.2% to 39475000.0 in 2025, then rose by 17.92% to 32400000.0 in 2026.
• The last three Cash from Operations figures came in at 32400000.0 (Q1 2026), 39475000.0 (Q4 2025), and 107804000.0 (Q3 2025), per Business Quant data.